These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38162885)

  • 21. A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity
    Guo Q; Xu L; Tan F; Zhang Y; Fan J; Wang X; Zhang Z; Li B; Chu H
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0088921. PubMed ID: 34460305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel oxazolidinones harbor potent
    Wang C; Wang G; Huo F; Xue Y; Jia J; Dong L; Zhao L; Wang F; Huang H; Duan H
    Front Med (Lausanne); 2022; 9():1067516. PubMed ID: 36523787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC; Hallbauer UM; Seddon JA; Hesseling AC; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis.
    Wu J; Yang X; Wu J; Wang J; Wu H; Wang Y; Yuan H; Yang H; Wang H; Zhang J
    Front Pharmacol; 2023; 14():1135007. PubMed ID: 36992830
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of
    Zong Z; Jing W; Shi J; Wen S; Zhang T; Huo F; Shang Y; Liang Q; Huang H; Pang Y
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerability and Pharmacokinetics of Contezolid at Therapeutic and Supratherapeutic Doses in Healthy Chinese Subjects, and Assessment of Contezolid Dosing Regimens Based on Pharmacokinetic/Pharmacodynamic Analysis.
    Wu J; Wu H; Wang Y; Chen Y; Guo B; Cao G; Wu X; Yu J; Wu J; Zhu D; Guo Y; Yuan H; Hu F; Zhang J
    Clin Ther; 2019 Jun; 41(6):1164-1174.e4. PubMed ID: 31126694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Pharmacology and Utility of Contezolid in Chinese Patients with Complicated Skin and Soft-Tissue Infections.
    Yuan H; Wu H; Zhang Y; Huang H; Li Y; Wu J; Cao G; Yu J; Guo B; Wu J; Yuan Z; Chen Y; Yang W; Wu X; Zhang J
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0243021. PubMed ID: 35575579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical toxicity evaluation of novel antibacterial contezolid acefosamil in rats and dogs.
    Wang W; Li Z; Gordeev MF; Yuan H
    J Appl Toxicol; 2024 May; 44(5):770-783. PubMed ID: 38237604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linezolid for drug-resistant pulmonary tuberculosis.
    Singh B; Cocker D; Ryan H; Sloan DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012836. PubMed ID: 30893466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria.
    Oehadian A; Santoso P; Menzies D; Ruslami R
    Tuberc Respir Dis (Seoul); 2022 Apr; 85(2):111-121. PubMed ID: 35045688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis.
    Cox H; Ford N
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):447-54. PubMed ID: 22325685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contezolid-Containing Regimen Successfully Treated Multiple Drug Resistance Mycobacterium Abscessus Complex Infection of Skin: A Case Report and Literature Review.
    Gao X; Ding C; Xie D; Wang Q; Jiang P; Wang Y; Xiong Y
    Infect Drug Resist; 2024; 17():1243-1249. PubMed ID: 38560704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sepsis and pneumonia caused by Enterococcus faecium following liver transplantation treated with contezolid as the first-line therapy.
    Liu X; Wang Z; Wu W; Zheng S
    J Glob Antimicrob Resist; 2024 May; 38():1-5. PubMed ID: 38777179
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Carvalhaes CG; Duncan LR; Wang W; Sader HS
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32778552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the Effect of Contezolid (MRX-I) on the Corrected QT Interval in a Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study in Healthy Chinese Volunteers.
    Wu J; Cao G; Wu H; Chen Y; Guo B; Wu X; Yu J; Ni K; Qian J; Wang L; Wu J; Wang Y; Yuan H; Zhang J; Xi Y
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32229495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis.
    Condos R; Hadgiangelis N; Leibert E; Jacquette G; Harkin T; Rom WN
    Chest; 2008 Jul; 134(1):187-92. PubMed ID: 18628223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contezolid: First Approval.
    Hoy SM
    Drugs; 2021 Sep; 81(13):1587-1591. PubMed ID: 34365606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxazolidinone: A promising scaffold for the development of antibacterial drugs.
    Yuan S; Shen DD; Bai YR; Zhang M; Zhou T; Sun C; Zhou L; Wang SQ; Liu HM
    Eur J Med Chem; 2023 Mar; 250():115239. PubMed ID: 36893700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
    Xu HB; Jiang RH; Li L; Xiao HP
    Int J Tuberc Lung Dis; 2012; 16(3):358-63. PubMed ID: 22640450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and Disposition of Contezolid in Humans: Resolution of a Disproportionate Human Metabolite for Clinical Development.
    Wu X; Meng J; Yuan H; Zhong D; Yu J; Cao G; Liu X; Guo B; Chen Y; Li Y; Shi Y; Gordeev MF; Wu J; Zhang J
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0040921. PubMed ID: 34398672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.